141 related articles for article (PubMed ID: 31953417)
21. Effects of Marital Status on Prognosis in Women with Infiltrating Ductal Carcinoma of the Breast: A Real-World 1: 1 Propensity-Matched Study.
Lan T; Lu Y; Luo H; He J; He J; Hu Z; Xu H
Med Sci Monit; 2020 Jun; 26():e923630. PubMed ID: 32581209
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and overall survival prognostic nomogram for invasive cribriform carcinoma of breast: a SEER population-based analysis.
Liu J; Zheng X; Han Z; Lin S; Han H; Xu C
BMC Cancer; 2021 Feb; 21(1):168. PubMed ID: 33593316
[TBL] [Abstract][Full Text] [Related]
23. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials.
Huober J; Gelber S; Goldhirsch A; Coates AS; Viale G; Öhlschlegel C; Price KN; Gelber RD; Regan MM; Thürlimann B
Ann Oncol; 2012 Nov; 23(11):2843-2851. PubMed ID: 22707751
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implications of lobular breast cancer histology: new insights from a single hospital cross-sectional study and SEER data.
Brouckaert O; Laenen A; Smeets A; Christiaens MR; Vergote I; Wildiers H; Moerman P; Floris G; Neven P;
Breast; 2014 Aug; 23(4):371-7. PubMed ID: 24530094
[TBL] [Abstract][Full Text] [Related]
25. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
26. Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast.
Chen AC; Paulino AC; Schwartz MR; Rodriguez AA; Bass BL; Chang JC; Teh BS
Br J Cancer; 2014 Jul; 111(3):619-22. PubMed ID: 24921921
[TBL] [Abstract][Full Text] [Related]
27. Dose invasive apocrine adenocarcinoma has worse prognosis than invasive ductal carcinoma of breast: evidence from SEER database.
Zhang N; Zhang H; Chen T; Yang Q
Oncotarget; 2017 Apr; 8(15):24579-24592. PubMed ID: 28445946
[TBL] [Abstract][Full Text] [Related]
28. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
29. Nomogram for predicting preoperative lymph node involvement in patients with invasive micropapillary carcinoma of breast: a SEER population-based study.
Ye FG; Xia C; Ma D; Lin PY; Hu X; Shao ZM
BMC Cancer; 2018 Nov; 18(1):1085. PubMed ID: 30409127
[TBL] [Abstract][Full Text] [Related]
30. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Eur J Cancer; 1995 Dec; 31A(13-14):2289-95. PubMed ID: 8652258
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.
Liu XY; Jiang YZ; Liu YR; Zuo WJ; Shao ZM
Medicine (Baltimore); 2015 Aug; 94(31):e1309. PubMed ID: 26252312
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.
Roberts MC; Miller DP; Shak S; Petkov VI
Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896
[TBL] [Abstract][Full Text] [Related]
33. Construction and Validation of Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Nonmetastatic Inflammatory Breast Cancer Patients Receiving Tri-Modality Therapy: A Population-Based Study.
Huang Q; Xu TY; Wu ZY
Med Sci Monit; 2019 Dec; 25():9167-9178. PubMed ID: 31789307
[TBL] [Abstract][Full Text] [Related]
34. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
Wu W; Wu M; Peng G; Shi D; Zhang J
Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
[TBL] [Abstract][Full Text] [Related]
35. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma.
Wu SG; Yang SP; Zhang WW; Wang J; Lian CL; Chen YX; He ZY
Sci Rep; 2020 Dec; 10(1):22070. PubMed ID: 33328559
[TBL] [Abstract][Full Text] [Related]
36. Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma.
Adachi Y; Ishiguro J; Kotani H; Hisada T; Ichikawa M; Gondo N; Yoshimura A; Kondo N; Hattori M; Sawaki M; Fujita T; Kikumori T; Yatabe Y; Kodera Y; Iwata H
BMC Cancer; 2016 Mar; 16():248. PubMed ID: 27015895
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population-based study.
Yang LP; Sun HF; Zhao Y; Chen MT; Zhang N; Jin W
Cancer Med; 2017 Dec; 6(12):2867-2875. PubMed ID: 29131529
[TBL] [Abstract][Full Text] [Related]
38. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study.
Dai D; Jin H; Wang X
Am J Cancer Res; 2018; 8(8):1576-1585. PubMed ID: 30210925
[TBL] [Abstract][Full Text] [Related]
39. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
40. Adenosquamous carcinoma of the breast: a population-based study.
Xu C; Gu Z; Liu J; Lin X; Wang C; Li J; Fu Y; Cheng X; Zhuang Z
Breast Cancer; 2021 Jul; 28(4):848-858. PubMed ID: 33580464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]